Drug Profile
Research programme: nicotinamide adenine dinucleotide modulators - Mitobridge
Alternative Names: NAD+ modulators - MitobridgeLatest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator Ecole Polytechnique Federale de Lausanne.
- Developer Ecole Polytechnique Federale de Lausanne.; Mitobridge
- Class
- Mechanism of Action Nicotinamide adenine dinucleotide modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mitochondrial disorders